About LENSAR
LENSAR (NASDAQ:LNSR) specializes in advanced laser technology for the treatment of cataracts, focusing on delivering innovative solutions to ophthalmologists and their patients. The company's flagship product, the LENSAR Laser System, is designed for use in cataract surgery, utilizing unique imaging and laser techniques to enhance precision and safety. LENSAR aims to improve surgical outcomes, patient experience, and surgeon efficiency through continuous research and development. Their commitment to innovation is evident in their ongoing projects to expand device capabilities and explore new applications within eye surgery. The primary objective of LENSAR is to redefine the standards of ophthalmic surgery by leveraging their expertise in laser technology to benefit patients around the globe.
Snapshot
Operations
Products and/or services of LENSAR
- ALLY Adaptive Cataract Treatment System, a comprehensive solution employing femtosecond laser technology for enhanced cataract surgery precision.
- Streamline IV, an upgrade for precision and customisation in laser cataract surgeries, including advanced astigmatism management.
- Streamline III, integration of advanced imaging and laser technologies to improve efficiency and outcomes in cataract surgery.
- LENSAR Laser System, a femtosecond laser platform providing advanced tools for cataract removal with safety and precision.
- Augmented Reality technology, offering surgeons real-time, 3-D visualization for improved surgical planning and treatment.
- Cataract Refractive Suite, a collection of technologies aimed at increasing the accuracy and predictability of post-surgery refractive outcomes.
LENSAR executive team
- Mr. Nicholas T. CurtisPresident, CEO & Director
- Mr. Thomas R. Staab II, CPACFO & Secretary
- Mr. Alan B. ConnaughtonChief Operating Officer
- Ms. Kendra W. WongPrincipal Accounting Officer